期刊文献+

我院2011年门诊抗高血压药用药分析 被引量:1

下载PDF
导出
摘要 应用金额排序法和用药频度(DDDs)排序法,对我院门诊2011年所应用的抗高血压药的品种、用药金额、DDDs等指标进行统计分析。用药金额和频度排在前三位的药物均为钙离子拮抗剂(CCB)、血管紧张素转换酶抑制剂(ACEI)、β-受体阻滞剂;DDDs排在前五位的药物苯磺酸氨氯地平(国产)、培哚普利片、贝那普利片、苯磺酸氨氯地平(进口)和吲达帕胺缓释片。说明我院门诊高血压用药基本合理。
作者 查静
出处 《海峡药学》 2013年第6期256-257,共2页 Strait Pharmaceutical Journal
  • 相关文献

参考文献5

二级参考文献42

  • 1张桂芬.我院2002-2004年抗感染药应用分析[J].中国医院药学杂志,2006,26(4):491-493. 被引量:20
  • 2MANCIA G, DEBACKER G, DOMINICZAK A, et al. 2007 Guidelines for the management of arterial hypertension : the task force for the management of arterial hypertension of the european society of hypertension (ESH) and of the european society of cardiology (ESC) [J]. Eur Heart J, 2007,28(12) :1462 - 1536.
  • 3MATCHAR D B, MCCRORY D C, ORLANDO L A, et al. Systematic review : comparative effectiveness of angiotensin- converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension [ J ]. Ann Intern Med, 2008,148(1) :16-29.
  • 4SAWADA T, TAKAHASHI T, YAMADA H, et al. Rationale and design of the Kyoto Heart Study: effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high risk of cardiovascular events [J]. Journal of Human Hypertension, 2009, 23: 188- 195.
  • 5MOCHIZUKI S, DAHLOF B, SHIMIZU M, et al. Valsartan in a Japanese population with hypertension and other cardiovascular disease ( Jikei Heart Study) : a randomised, open- label, blinded endpoint morbiditymortality study [ J]. Lancet,2007,369 : 1431 - 1439.
  • 6ZHU J R, FUJITA T, SHIMAMOTO K, et al. Implication of clinical studies for the Asian population: focus on Chinese/Asian population[J]. J Clin Pract, 2006, 60 (Suppl 150) : 14 - 16.
  • 7LINDHOLM L H, CARLBERG B, SAMUELSSON O. Shold β blockers remain first choice in the treatment of primary hypertension? a meta-analysis [ J ]. Lancet, 2005, 366 ( 9496 ) : 1545 - 1553.
  • 8BANGALORE S, PARKAR S, GROSSMAN E, et al. A meta-analysis of 94 492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus [ J ]. Am J Cardiol, 2007, 100 ( 8 ) : 1254 - 1262.
  • 9DAHLOF B, SEVER P S, POULTER N R, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA) : a muhicentre randomised controlled trial [ J ]. Lancet,2005,366 (9489) : 895 - 906.
  • 10WILLIAMS B, LACY P S, THOM S M, et al. Differential impact of blood pressure lowering drugs on central aortic pressure and clinical outcomes: principal results of the conduit artery function evaluation (CAFE) study [ J ]. Circulation, 2006,113 (9) : 1213 - 1225.

共引文献84

同被引文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部